MSF Access
@msfaccess.org
Starting now!
TB Ed Talk - TB In Children: What's The Problem And What Can We Do? from Dr. Stijn Deborggraeve
YouTube video by TBFighters
www.youtube.com
December 2, 2025 at 3:27 PM
Starting now!
We’re addressing AMR through dedicated prevention, detection, and response efforts across more than 20 countries, but there must be an increased global response.
Improving access to microbiology labs 🔬 & lifesaving medicines 💊 in places with the greatest needs is essential.
Improving access to microbiology labs 🔬 & lifesaving medicines 💊 in places with the greatest needs is essential.
November 20, 2025 at 12:20 PM
We’re addressing AMR through dedicated prevention, detection, and response efforts across more than 20 countries, but there must be an increased global response.
Improving access to microbiology labs 🔬 & lifesaving medicines 💊 in places with the greatest needs is essential.
Improving access to microbiology labs 🔬 & lifesaving medicines 💊 in places with the greatest needs is essential.
Ensuring people have access to insulin and diabetes care is essential, especially during emergencies and in humanitarian settings where diabetes care is even more limited.
Learn more ⬇️
msfaccess.org/what-it-mean...
Learn more ⬇️
msfaccess.org/what-it-mean...
What it means to lose access to diabetes care: stories from people living with diabetes around the world
Managing diabetes is complicated. Even with access to the best tools and technology, it requires constant blood sugar level monitoring and daily treatment in the form of medication or insulin.
msfaccess.org
November 14, 2025 at 11:14 AM
Ensuring people have access to insulin and diabetes care is essential, especially during emergencies and in humanitarian settings where diabetes care is even more limited.
Learn more ⬇️
msfaccess.org/what-it-mean...
Learn more ⬇️
msfaccess.org/what-it-mean...
In 2024, pharmaceutical corporation Novo Nordisk decided to stop producing human insulin pens (which Lecritia uses).
Although Novo committed to supply South Africa with another type of insulin pen – analogues – they are priced very high and may not result in equitable access.
Although Novo committed to supply South Africa with another type of insulin pen – analogues – they are priced very high and may not result in equitable access.
November 14, 2025 at 11:08 AM
In 2024, pharmaceutical corporation Novo Nordisk decided to stop producing human insulin pens (which Lecritia uses).
Although Novo committed to supply South Africa with another type of insulin pen – analogues – they are priced very high and may not result in equitable access.
Although Novo committed to supply South Africa with another type of insulin pen – analogues – they are priced very high and may not result in equitable access.
Lecritia, from South Africa, is comfortable using insulin pens.
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
November 14, 2025 at 11:08 AM
Lecritia, from South Africa, is comfortable using insulin pens.
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
"Antibiogo was developed in collaboration with the people and countries that need it."
We spoke on Antibiogo last week at the World Health Summit, sharing how it was developed by, for, and with the countries where we work.
www.youtube.com/watch?v=Oq6A...
#Innovation #WHS2025
We spoke on Antibiogo last week at the World Health Summit, sharing how it was developed by, for, and with the countries where we work.
www.youtube.com/watch?v=Oq6A...
#Innovation #WHS2025
The Future of Antibiotics: Is Global South Innovation Our Best Strategy? | GHL 05
YouTube video by World Health Summit
www.youtube.com
October 24, 2025 at 4:03 PM
"Antibiogo was developed in collaboration with the people and countries that need it."
We spoke on Antibiogo last week at the World Health Summit, sharing how it was developed by, for, and with the countries where we work.
www.youtube.com/watch?v=Oq6A...
#Innovation #WHS2025
We spoke on Antibiogo last week at the World Health Summit, sharing how it was developed by, for, and with the countries where we work.
www.youtube.com/watch?v=Oq6A...
#Innovation #WHS2025